CHELLI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 4.296
EU - Europa 2.874
AS - Asia 2.012
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 92
OC - Oceania 49
Totale 9.692
Nazione #
US - Stati Uniti d'America 4.217
RU - Federazione Russa 1.159
SG - Singapore 612
IT - Italia 563
CN - Cina 470
HK - Hong Kong 322
SE - Svezia 298
IE - Irlanda 293
BR - Brasile 208
VN - Vietnam 162
KR - Corea 157
DE - Germania 114
FI - Finlandia 114
CH - Svizzera 85
FR - Francia 78
JO - Giordania 70
IN - India 62
JP - Giappone 62
GB - Regno Unito 60
UA - Ucraina 60
CA - Canada 51
AU - Australia 47
CI - Costa d'Avorio 32
NG - Nigeria 25
BD - Bangladesh 21
AR - Argentina 16
MX - Messico 15
IQ - Iraq 14
ZA - Sudafrica 14
NL - Olanda 12
ES - Italia 11
PL - Polonia 10
TR - Turchia 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
PK - Pakistan 7
EC - Ecuador 6
MA - Marocco 5
CL - Cile 4
CO - Colombia 4
CY - Cipro 4
LT - Lituania 4
PH - Filippine 4
VE - Venezuela 4
AT - Austria 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
AL - Albania 2
BY - Bielorussia 2
HN - Honduras 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 9.569
Città #
Santa Clara 1.427
Singapore 417
Chandler 303
Dublin 292
Dallas 273
Hong Kong 263
Ashburn 257
Beijing 193
Seoul 157
Buffalo 102
Milan 100
Jacksonville 89
Fairfield 88
Bern 82
Council Bluffs 76
Lawrence 72
Los Angeles 71
Boston 68
Cambridge 67
Princeton 67
Altamura 64
Tokyo 61
Woodbridge 58
San Jose 56
The Dalles 55
Lauterbourg 54
Ho Chi Minh City 50
Melbourne 45
Munich 44
Rome 41
Wilmington 41
Florence 39
Hanoi 38
Hefei 38
Mumbai 36
Houston 34
Abidjan 32
Seattle 32
Helsinki 29
São Paulo 29
Ann Arbor 28
Kent 27
Moscow 26
New York 24
Abuja 23
Arezzo 20
Shanghai 20
Boardman 19
Medford 18
Ravenna 18
Redondo Beach 18
Turku 17
Phoenix 16
Bologna 15
London 15
Turin 15
Naples 14
Dearborn 13
Denver 13
Johannesburg 13
Miano 13
Norwalk 13
San Diego 13
Hillsboro 11
Toronto 11
Falls Church 10
Orem 10
Chennai 9
Da Nang 9
Frankfurt am Main 9
Warsaw 9
Yubileyny 9
Brooklyn 8
Falkenstein 8
Mexico City 8
Montreal 8
Poplar 8
Bari 7
Haiphong 7
Rio de Janeiro 7
Tashkent 7
Andover 6
Belo Horizonte 6
Frankfurt Am Main 6
Izmir 6
Leipzig 6
Palermo 6
Verona 6
West Jordan 6
Atlanta 5
Campinas 5
Genoa 5
Guangzhou 5
Newark 5
Brescia 4
Cagliari 4
Curitiba 4
Dhaka 4
Erbil 4
Figino 4
Totale 6.003
Nome #
Does an Aberrant Glucosylation Trigger Autoimmunity in Multiple Sclerosis? 209
N(alpha)-Fmoc-Protected omega-Azido and omega-Ynoic-alpha-Amino Acids as Building Blocks for the Synthesis of "Clickable" Peptides 192
Lipoderivatives of an immunodominant epitope of myelin basic protein increased T cell responsiveness in Lewis rats. 192
Microwave-assisted reaction of building blocks for glycopeptides synthesis. 190
EFFECT OF LIPOCONJUGATION ON MBP PEPTIDE EPITOPES FOR CD4+ T CELL RESPONSIVENESS 189
Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers 188
Synthesis of a new dicarba-analogue of the drug octreotide 180
Combinatorial approach to develop the optimal glycopeptide as molecular probe to characterize autoantibodies in Multiple Sclerosis. 180
Asparaginyl glucose is fundamental for autoantibody recognition in Multiple Sclerosis. 180
Identification of new autoantigens in Multiple Sclerosis by glycopeptide libraries 177
Modeling of copper(II) sites in proteins based on histidyl and glycyl residues 177
Beta-Hairpin glycopeptides as mimetic autoantigens in multiple sclerosis 175
A comparative study on new not azabenzotriazole-based coupling reagents for SPPS 171
NEW GLYCOSYLATED BUILDING-BLOCKS USEFUL FOR GLYCOPEPTIDE SYNTHESIS 169
Electrochemical Glycopeptide Probes to Detect Autoantibodies in Multiple Sclerosis Patients’ Sera. 169
An efficient microwave-assisted synthesis of 2,5-diketopiperazines libraries 167
SYNTHESIS OF A DICARBA- ANALOGUE OF OCTEOTRIDE KEEPING THE TYPE II BETA-TURN OF THE PHARMACOPHORE IN WATER SOLUTION 166
Automatic microwave glycopeptide synthesis via a new generation of triazine-based coupling reagents. 163
Identification of the minimal epitope(s) mimicked by the synthetic glucopeptide CSF114(Glc). 160
A proteomic approach to characterize a native antigen involved in autoantibody response in Multiple Sclerosis by a structure-based designed glycopeptide. 160
An universal peptide scaffold to develop antigenic probes specific for autoimmune diseases. 157
Beta-hairpin glycopeptides as mimetic autoantigens in Multiple Sclerosis 156
Identification of new autoantigens in Multiple Sclerosis by glycopeptide libraries 154
A new generation of N-triazinylammonium coupling reagents versatile for peptide synthesis by different strategies 153
Improvement of autoantibody detection in autoimmune diseases by innovative solid-phase glycopeptide based technologies. 152
Celiac disease: characterization of linear autoantigenic epitopes. 150
Celiac disease: characterization of amino acids/short peptides finger print for a fast ivd. 147
Synthesis and conformational studies of a new octreotide analogue 147
A new synthetic approach to saturated and unsaturated dicarba-analogues of octeotride. 146
A Glycopeptide-based Technique for Selective Antibodies Purification. 144
Mimicry effect of the neo-epitope [Asn641(Glc)]FAN(635-655) with CSF114(Glc) detecting autoantibodies in Multiple Sclerosis 144
A chemical reverse approach for autoimmune diseases diagnosis. 144
Conventional and microwave-assisted SPPS approach: a comparative study of PTHrP(1-34)NH2 synthesis. 144
Ribose building block for the synthesis of glycopeptides to fishing out antibodies in autoimmune diseases. 143
Sugar–Scan of CSF114(Glc) for autoantibody recognition in autoimmune diseases. 141
A solid-phase synthesis of tetraazamacrocycles from cyclotetrapeptides 141
Assessment of 6Cl-HOBt-based coupling reagents in solid-phase cyclopeptide synthesis. 141
An innovative approach to the synthesis of N-glycopeptides 140
Synthesis of 17-(2-oxo-4-imidazolin-4-yl) Derivatives from Cortexone and Cortisone 140
Microwave-Assisted Solid Phase Synthesis of Backbone Cyclic Glycopeptide Libraries. 137
Optimized conditions for glycopeptide synthesis by a microwave peptide synthesizer. 136
Microwave-assisted synthesis of glycosylated building blocks. 135
An efficient microwave-assisted soli-phase synthesis of Gramicidin A for studies in bilayer lipid membrane. 134
Ferrocenyl Glycopeptides as Electrochemical Probes to Detect Autoantibodies in Multiple Sclerosis Patients’ Sera 133
Microwave-assisted solid-phase synthesis of collagen peptides 132
Structure-activity relationship study of glycopeptide antigens recognizing specific autoantibodies in Multiple Sclerosis. 132
MS PepKit. The First Diagnostic Test to Follow-up Multiple Sclerosis 131
Microwave-assisted solid-phase synthesis of peptide probes to detect specific biomarkers: shifting off limitations affecting conventional synthetic strategies. 130
Synthetic strategies for forming the glycan-peptide linkage 128
Conformationally driven rational design of glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis. 128
Semi-synthesis of glucosylated recombinant MOG as auto-antigen in multiple sclerosis. 126
Identification of cytoskeletal proteins monoclonal antibodies recognized by CSF114(Glc), the synthetic probe of Multiple Sclerosis. 126
Synthesis of newly designed peptides for the diagnosis of Celiac Disease. 125
Synthetic strategies to Advanced Glycation End products peptides involved in diabetes. 123
Microwave-assisted solid phase synthesis of [Asn641(Glc)]FAN(635-655): a new case study for optimisation of glycopeptide synthesis 123
Modified peptides as diagnostic tools for autoimmune diseases: A chemical reverse approach. 120
Synthesis of useful building blocks for peptide synthesis: a comparative study of different coupling reagents for ester and amide bonds 117
Sugar building blocks for solid-phase glycopeptides synthesis. 116
Rational design and optimization of newly designed glycopeptide to develop the diagnostic/prognostic assays for Multiple Sclerosis 115
New generation of triazine-based coupling reagents useful for SPPS 113
New Generation of Families of Antigenic Probes for Detection of Multiple Sclerosis Biomarkers. 108
Towards a therapeutic apheresis in Multiple Sclerosis based on a glycopeptide antigen able to isolate specific autoantibodies. 107
Microwave-assisted attachment of Fmoc-amino acids to resins via triazine superactive esters. 106
Peptide-based immunoassays: a challenge for high performance diagnostics & prognostics of autoimmune diseases. 94
Post translational modified peptide-based ELISA to detect autoantibodies in Primary Biliary Cirrhosis. 89
Optimisation of synthetic strategies to glycosylated amino acids 83
New ribosylated building blocks useful for glycopeptide synthesis.. 77
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases 17
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases 13
Totale 9.692
Categoria #
all - tutte 27.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022318 0 0 4 41 8 3 0 36 6 5 80 135
2022/20231.310 101 204 75 67 97 230 175 65 183 1 25 87
2023/2024456 27 54 72 14 12 32 87 87 2 12 44 13
2024/20253.480 112 343 212 510 1.029 640 62 158 161 59 96 98
2025/20262.965 378 567 244 161 326 84 240 108 207 160 73 417
2026/2027200 91 99 10 0 0 0 0 0 0 0 0 0
Totale 9.692